Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges

Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

Article  PubMed  Google Scholar 

Ga H, et al. Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy. Arch Gynecol Obstet. 2023;308:1629–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

ACoOa. Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia: ACOG clinical consensus No. 5. Obstet Gynecol. 2023;142:735–44.

Article  Google Scholar 

Kolatorova L, Vitku J, Suchopar J, Hill M, Parizek A. Progesterone: a steroid with wide range of effects in physiology as well as human medicine. Int J Mol Sci. 2022;23:7989.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murata H, Tanaka S, Okada H. The regulators of human endometrial stromal cell decidualization. Biomolecules. 2022;12:1275.

Article  CAS  PubMed  PubMed Central  Google Scholar 

King L, Gajarawala S, McCrary MD. Endometrial cancer and obesity: addressing the awkward silence. JAAPA. 2023;36:28–31.

Article  PubMed  Google Scholar 

Rütten H, et al. Recurrent endometrial cancer: local and systemic treatment options. Cancers (Basel). 2021;13:6275.

Article  PubMed  Google Scholar 

Hirschberg AL. Sex hormones, appetite and eating behaviour in women. Maturitas. 2012;71:248–56.

Article  CAS  PubMed  Google Scholar 

Levi F, La Vecchia C, Negri E, Parazzini F, Franceschi S. Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer. 1992;50:567–71.

Article  CAS  PubMed  Google Scholar 

Petrelli F, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e213520.

Article  PubMed  PubMed Central  Google Scholar 

Lauby-Secretan B, et al. Body fatness and cancer—viewpoint of the IARC working group. N Engl J Med. 2016;375:794–8.

Article  PubMed  PubMed Central  Google Scholar 

Recalde M, et al. Longitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults. Nat Commun. 2023;14:3816.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung H, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69:88–112.

Article  PubMed  Google Scholar 

Terzic M, et al. Molecular basis of endometriosis and endometrial cancer: current knowledge and future perspectives. Int J Mol Sci. 2021;22:9274.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, et al. Insulin resistance and metabolic syndrome increase the risk of relapse for fertility preserving treatment in atypical endometrial hyperplasia and early endometrial cancer patients. Front Oncol. 2021;11:744689.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crosbie EJ, et al. Endometrial cancer. Lancet. 2022;399:1412–28.

Article  PubMed  Google Scholar 

Stępień S, Olczyk P, Gola J, Komosińska-Vassev K, Mielczarek-Palacz A. The role of selected adipocytokines in ovarian cancer and endometrial cancer. Cells. 2023;12:1118.

Article  PubMed  PubMed Central  Google Scholar 

Rodriguez AC, Blanchard Z, Maurer KA, Gertz J. Estrogen signaling in endometrial cancer: a key oncogenic pathway with several open questions. Horm Cancer. 2019;10:51–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hernandez AV, et al. Insulin resistance and endometrial cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2015;51:2747–58.

Article  CAS  PubMed  Google Scholar 

Yang X, Wang J. The role of metabolic syndrome in endometrial cancer: a review. Front Oncol. 2019;9:744.

Article  PubMed  PubMed Central  Google Scholar 

Kim SI, Kim JW. Endometrial cancer. N Engl J Med. 2021;384:586.

Article  PubMed  Google Scholar 

Vasim I, Majeed CN, DeBoer MD. Intermittent fasting and metabolic health. Nutrients. 2022;14:631.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Z, Heber D. Intermittent fasting. JAMA. 2021;326:1338.

Article  PubMed  Google Scholar 

Rawat K, Singh N, Kumari P, Saha L. A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective. Rev Neurosci. 2021;32:143–57.

Article  CAS  PubMed  Google Scholar 

Gallage S, et al. A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARalpha and PCK1. Cell Metab. 2024;36:1371-1393.e7.

Article  CAS  PubMed  Google Scholar 

Zhong W, et al. High-protein diet prevents fat mass increase after dieting by counteracting Lactobacillus-enhanced lipid absorption. Nat Metab. 2022;4:1713–31.

Article  CAS  PubMed  Google Scholar 

Ferrer M, et al. Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia. Cell Metab. 2023;35:1147-1162.e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

MoTrPAC Study Group, Lead Analysts & MoTrPAC Study Group. Temporal dynamics of the multi-omic response to endurance exercise training. Nature. 2024;629:174–83.

Article  Google Scholar 

Wen Q, et al. Research trends and hotspots in exercise rehabilitation for coronary heart disease: a bibliometric analysis. Med (Baltim). 2023;102:e36511.

Article  Google Scholar 

McDermott MM. Home-based walking exercise for peripheral artery disease. JAMA. 2022;327:1339–40.

Article  PubMed  Google Scholar 

Skolnik N. The American Academy of Pediatrics Obesity Guidelines-a critical appraisal. JAMA Pediatr. 2023;177:747–8.

Article  PubMed  Google Scholar 

Kim BY, et al. 2020 Korean society for the study of obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr. 2021;30:81–92.

Article  PubMed  PubMed Central  Google Scholar 

Jensen MD, Ryan DH. New obesity guidelines: promise and potential. JAMA. 2014;311:23–4.

Article  CAS  PubMed  Google Scholar 

Vaziri-Gohar A, et al. Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors. Nat Cancer. 2022;3:852–65.

Article 

Comments (0)

No login
gif